Learn More About Our In-Licensing Programs Antivenoms and Q fever vaccine Learn More About These Programs Report an Adverse Event/Undesirable Effect Please contact us if you believe that you or a loved one has had any type of adverse reaction to any of our treatments. ...
Learn More About Our In-Licensing Programs Antivenoms and Q fever vaccine Learn More About These Programs Report an Adverse Event/Undesirable Effect Please contact us if you believe that you or a loved one has had any type of adverse reaction to any of our treatments. ...
Influenza Vaccines COVID-19 Vaccines Pandemic Response In-Licensing Antivenoms and Q fever vaccine Our Manufacturing Expertise CSL Seqirus operates state-of-the-art manufacturing facilities on three different continents and a globally integrated supply chain for the timely supply of influenza vaccine to ...
Influenza Vaccines COVID-19 Vaccines Pandemic Response In-Licensing Antivenoms and Q fever vaccine Our Manufacturing Expertise CSL Seqirus operates state-of-the-art manufacturing facilities on three different continents and a globally integrated supply chain for the timely supply of influenza vaccine to ...
Influenza Vaccines COVID-19 Vaccines Pandemic Response In-Licensing Antivenoms and Q fever vaccine Our Manufacturing Expertise CSL Seqirus operates state-of-the-art manufacturing facilities on three different continents and a globally integrated supply chain for the timely supply of influenza vaccine to ...
Influenza Vaccines COVID-19 Vaccines Pandemic Response In-Licensing Antivenoms and Q fever vaccine Our Manufacturing Expertise CSL Seqirus operates state-of-the-art manufacturing facilities on three different continents and a globally integrated supply chain for the timely supply of influenza vaccine to ...
Influenza Vaccines COVID-19 Vaccines Pandemic Response In-Licensing Antivenoms and Q fever vaccine Our Manufacturing Expertise CSL Seqirus operates state-of-the-art manufacturing facilities on three different continents and a globally integrated supply chain for the timely supply of influenza vaccine to ...
它为北半球和南半球市场提供流感疫苗,并提供covid-19相关的防备和应对方案。Seqirus在澳大利亚和亚太地区提供经许可的疫苗和特种药品。它还为免疫血液实验室生产和销售诊断产品。它是澳大利亚政府的供应商,包括抗蛇毒血清和Q fever疫苗。2019财年,Seqirus的营收为1.0181亿美元,占公司营收的12.4%。
In November 2020, CSL Seqirus announced the build of the only cell-based influenza vaccine manufacturing facility in the Southern Hemisphere, producing seasonal and pandemic influenza vaccines, CSL Seqirus proprietary adjuvant and Australian antivenoms and Q-Fever vaccine. The facility will be built at...
Ackland JR, Worswick DA, Marmion BP. Vaccine prophylaxis of Q Fever. A follow-up study of the efficacy of Q-Vax (CSL) 1985-1990. Med J Aust 1994;160:704-708.Marmion BP. Vaccine prophylaxis of Q Fever. In: Carangis J, Compiler. 200 Year celebration of vaccine development. Adelaide: ...